THE DEFINITIVE GUIDE TO PMTA 0 11

Additionally, it addresses the FDA’s communications While using the applicant, the retention of information that support the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may transfer ownership of the SE report back to a fresh applicant and Digital submission on the SE report an